CL.CN
Cresco Labs Inc
Price:  
1.42 
CAD
Volume:  
407,700.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CL.CN EV/EBITDA

5.6%
Upside

As of 2024-12-13, the EV/EBITDA ratio of Cresco Labs Inc (CL.CN) is 12.99. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CL.CN's latest enterprise value is 1,445.00 mil CAD. CL.CN's TTM EBITDA according to its financial statements is 111.23 mil CAD. Dividing these 2 quantities gives us the above CL.CN EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 11.6x - 13.7x 12.1x
Forward P/E multiples 18.9x - 31.3x 20.8x
Fair Price 0.34 - 3.01 1.50
Upside -76.2% - 111.6% 5.6%
1.42 CAD
Stock Price
1.50 CAD
Fair Price

CL.CN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-11-20 9.89
2024-11-19 9.95
2024-11-18 10.32
2024-11-15 10.75
2024-11-14 10.72
2024-11-13 10.86
2024-11-12 10.23
2024-11-11 9.35
2024-11-08 10.06
2024-11-07 10.12
2024-11-06 9.72
2024-11-05 11.09
2024-11-04 11.17
2024-11-01 11.23
2024-10-31 10.95
2024-10-30 11.00
2024-10-29 11.23
2024-10-28 11.40
2024-10-25 11.63
2024-10-24 11.57
2024-10-23 11.86
2024-10-22 11.77
2024-10-21 11.29
2024-10-18 11.34
2024-10-17 11.32
2024-10-16 11.26
2024-10-15 11.32
2024-10-11 11.40
2024-10-10 11.43
2024-10-09 11.54
2024-10-08 11.52
2024-10-07 11.49
2024-10-04 11.49
2024-10-03 11.54
2024-10-02 11.40
2024-10-01 11.46
2024-09-30 11.54
2024-09-27 11.49
2024-09-26 11.60
2024-09-25 11.60
2024-09-24 11.72
2024-09-23 11.52
2024-09-20 11.32
2024-09-19 11.52
2024-09-18 11.46
2024-09-17 11.54
2024-09-16 11.72
2024-09-13 11.60
2024-09-12 11.57
2024-09-11 11.54